Table 2.
Medication | Dosage |
---|---|
Amitriptyline | 25–75 mg po qhs |
Cimetidine | 400 mg po bid |
Hydroxyzine | 10–50 mg po qhs |
Oral pentosan polysulfate (PPS) | 100 mg po tid |
Intravesical pentosan polysulfate | 200 mg PPS mixed with 30 mL sterile buffered NS retained for 30–60 minutes |
Cyclosporine A | 2–3 mg/kg divided bid |
Gabapentin | 300–2100 mg po divided tid |
Quercetin | 500 mg po bid |
Intravesical dimethysulfoxide (DMSO) | 50 mL solution of 50% DMSO (Rimso-50) for 30–60 minutes, once weekly for six weeks; monthly maintenance prn |
Intravesical heparin | 20 000–40 000 IU of heparin diluted in 10 mL NS for 30–60 minutes, weekly for 4–6 weeks |
Intravesical hyaluronic acid | 40 mg/50 mL vial (Cystistat®), weekly instillations for 4–12 treatments, then monthly until symptoms resolve |
Intravesical chondroitin sulfate (CS) | 20 mL vial of 2.0% CS (Uracyst®), retained 30 minutes, weekly for six weeks, then monthly until symptoms resolve |
Intravesical alkalinized lidocaine | 200 mg lidocaine, alkalinized with a sequential instillation of 8.4% NaHCO3 solution, to a final volume of 10 mL (Urolieve®, PSD597) |
Intravesical oxybutynin | 10 mg oxybutynin (crushed tablets) diluted in 500 mL NS instilled until first sensation; weekly for six weeks, then monthly for three months |
Hydrodistension (HD) | Therapeutic HD under spinal or general anesthesia, where the bladder is filled with NS by gravity drainage at a pressure of 80 cm H2O to its capacity and distension is maintained for two to no more than 10 minutes; the bladder is drained at the end and capacity is measured |
Triamcinolone (steroid) injection for Hunner’s lesions | 1 mL vial of triamcinolone (40 mg/mL) diluted in 9 mL NS (total 10mL), to be injected in aliquots of 1 mL |
Botulinum toxin A | 100U suburothelial injection ± trigone |
bid: twice daily; IC/BPS: interstitial cystitis/bladder pain syndrome; NaHCO3: sodium bicarbonate; NS: normal saline; po: orally; qhs: every night at bedtime; tid: three times daily.